'No silver bullet': Investors cautioned as market surges on vaccine hopes

Healthcare analysts have cautioned investors against blind optimism for long-term gains after the ASX surged on Tuesday morning on positive news about a possible coronavirus vaccine.

Local medtechs across the board have been pivoting their research to coronavirus treatments and cures, with some seeing big share price gains. Stem cell companyDespite this, analysts warn investors that there are hurdles in the way for companies hoping to achieve share price gains from treatment research.

Ms Quinn ceased coverage of Mesoblast earlier this year but observed that while the company had taken its first steps into research, "they don’t yet have a track record of launching a product". "My sense is that there’s quite an onus on these companies to take a humanitarian as opposed to commercial point of view," she said.

MsEmmaK The only information you can believe is anything depressing and negative. They will always be truthful. But Always be cautious on anything positive.

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Stocks surge after Moderna announces promising early vaccine resultsThe first coronavirus vaccine tested on humans appears to be safe and able to stimulate an immune response against the virus, an early study has found | KnottMatthew KnottMatthew If a corporate mainstream propaganda outlet is telling you Coronavirus vaccine is 'safe', you just know it's going to be terrible, and should probably be avoided at all costs. Luckily, it's 'our body, or choice' right...right? VaccineMandateHereWeComeBaby KnottMatthew Appears to be....ok. FortWorthFan4 KnottMatthew I hope this is true. But do they have a vaccine against dumb yet? That seems to be a more prevalent condition in this country than any other.
Source: smh - 🏆 6. / 80 Read more »